Rewalk Robotics (NASDAQ:RWLK) issued its quarterly earnings data on Thursday. The medical device company reported ($0.88) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.39), Fidelity Earnings reports. The firm had revenue of $0.88 million during the quarter, compared to analysts’ expectations of $2.48 million.
Shares of RWLK traded down $0.09 on Friday, reaching $3.38. 250,447 shares of the company’s stock traded hands, compared to its average volume of 195,622. The company has a current ratio of 1.84, a quick ratio of 1.50 and a debt-to-equity ratio of 3.50. The business has a 50 day moving average price of $4.12. Rewalk Robotics has a 52-week low of $2.46 and a 52-week high of $30.00.
RWLK has been the subject of several analyst reports. ValuEngine raised Rewalk Robotics from a “hold” rating to a “buy” rating in a research note on Tuesday, July 2nd. Zacks Investment Research raised Rewalk Robotics from a “hold” rating to a “buy” rating and set a $3.00 price objective for the company in a research note on Thursday, May 16th. Finally, HC Wainwright raised Rewalk Robotics from a “neutral” rating to a “buy” rating and increased their price target for the company from $4.00 to $9.00 in a research report on Monday, June 17th.
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.
Featured Article: Analyst Ratings Trading
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.